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Abstract
The role of state anxiety and state fear in placebo effects is still to be determined. We aimed
to investigate the effect of fear of movement-related pain (FMRP) and contextual pain
related anxiety (CPRA) on the magnitude of placebo analgesia induced by verbal sugges-
tion. Fifty-six female participants completed a modified voluntary joystick movement para-
digm (VJMP) where half participated in a predictable pain condition (PC), in which one of the
joystick movements is always followed by pain and the other movement is never followed by
pain, and half in an unpredictable pain condition (UC), in which pain was delivered unpredict-
ably. By varying the level of pain predictability, FMRP and CPRA were induced in PC and
UC respectively. Colour stimuli were presented at the beginning of each trail. Half of the par-
ticipants were verbally informed that the green or red colour indicated less painful stimuli
(experimental groups), the other half did not receive any suggestion (control groups). We
measured self-reported pain intensity, expectancy of pain intensity (PC only), pain related
fear and anxiety (eyeblink startle response and self-ratings) and avoidance behaviour
(movement-onset latency and duration). The results indicate that the placebo effect was
successfully induced in both experimental conditions. In the PC, the placebo effect was pre-
dicted by expectancy. Despite the fact that FMRP and CPRA were successfully induced, no
difference was found in the magnitude of the placebo effect between PC and UC. Conclud-
ing, we did not find a divergent effect of fear and anxiety on placebo analgesia.
1. Introduction
There are only a few studies that investigated negative emotional states (anxiety and fear) in a
context of placebo analgesia [1–6]. Anxiety is a person’s current level of aversive emotional
state modulated by situational factors [7] that entails an appraisal of uncertain or uncontrolla-
ble threat [8,9], whereas fear is an aversive reaction elicited by the perception of a specific
threat stimulus, whether conditioned or not [8]. In general placebo was shown to affect pain
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by reducing negative emotional states [1,3,5,6]. Nevertheless, in most previous studies it is
unclear whether anxiety or fear was measured because state anxiety and state fear should be
elicited by the threat of shock [10] and fear-conditioning paradigm [8], respectively. Further-
more, some authors use either ‘fear’ or ‘anxiety’ [3,4] as synonyms rather than different psy-
chological phenomena. As a result, it is not clear what actually influences placebo effects: fear,
anxiety, or both. To address this question there is a need to experimentally differentiate
between both emotions.
The voluntary joystick movement paradigm (VJMP) developed by Meulders et al. [11–14]
offers a good way to experimentally induce state fear and state anxiety. The VJMP is a pain-rel-
evant fear-conditioning paradigm [12] in which extremity movements function as conditioned
stimuli (CSs) and painful stimuli as unconditioned stimuli (USs). In this paradigm, fear of
movement-related pain (FMRP) and contextual pain related anxiety (CPRA) [8,15] are elicited
in two experimental conditions, respectively: a predictable pain condition (PC) and an unpre-
dictable pain condition (UC). In PC, CS (joystick arm movement) are paired (CS+) or not
paired (CS-) with painful US (electric shock) which, after a few repetitions, results in a more
fearful response (conditioned response) to the movement that is always followed by a painful
stimulus (CS+). In the UC, pain stimuli are delivered in time intervals regardless of the joystick
movement. As a result this latter condition induces state anxiety.
Verbal suggestion is one of the main methods of eliciting the placebo effect [16–20]. As
such, in the current study we used verbal suggestion to induce the placebo effect in the colour
stimuli paradigm [21,22] combined with VJMP. In accordance to previous studies [1,5], it is
hypothesised that the use of placebo will reduce negative emotional states and induce placebo
analgesia. Moreover, it is predicted that a lower placebo effect would be observed in UC com-
pared to PC, as uncertainty have been associated with increased pain ratings [11]. To check if
experimental manipulations induced different emotional states, both subjective and physiolog-
ical measures were used as a manipulation check.
Placebo effects are suggested to be mediated by conscious expectations [20,23–26], how-
ever, the exact role of expectations in the induction of placebo analgesia via verbal suggestion
have not been unequivocally confirmed. Only a few placebo studies attempted to measure
expectations [1,2,4,20,27–29] and even fewer measured expectations on a trial-by-trial basis
[30–32]. Therefore, we aimed to investigate to what extent trial-by-trial expectancy of pain
intensity (only in PC) could predict the placebo effect induced by verbal suggestion.
2. Materials and methods
2.1. Participants
Fifty-nine right-handed, female volunteers (mean age = 24.10 years SD = 4.60, range = 19–49
years) participated in this study. Volunteers were recruited amongst the student population of
the Radboud University Nijmegen, the Netherlands, and received remuneration for participa-
tion in the study. All participants were healthy, free of pain and not taking any pain medica-
tions. Exclusion criteria included pregnancy, neurological, cardiovascular and respiratory
diseases, psychiatric disorders and hearing problems. Three participants were excluded from
the analyses: two due to technical problems and one due to very slow joystick movements dur-
ing the experiment and a large age difference (age 49 is considered too high compared to the
age range of 19 to 37 of the other participants). Data of the remaining 56 participants were fur-
ther analysed (mean age = 23.66 years SD = 3.27, range = 19–37 years). They were randomly
assigned to one of the four groups: two experimental (Group 1 and 3) and two control groups
(Group 2 and 4). Each group consisted of 14 participants (see Table 1).
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The participants were informed that they were participating in a study with the objective of
determining how fast they could move the joystick when pain stimuli were delivered to their
hand. All participants signed a written informed consent prior to the experiment. They were
also informed that they could stop participating at any point during the study without giving a
reason. The study was approved by the institutional ethics committee of Radboud University
in Nijmegen (ECG2012-1301- 005) and by the Research Ethics Committee at the Institute of
Psychology of Jagiellonian University in Krako´w, Poland.
2.2. Stimuli materials
2.2.1. Electrocutaneous stimuli. Electrocutaneous pain stimuli of 200 μs duration were
delivered to the volar surface of the dominant forearm through two durable stainless-steel disk
electrodes 8 mm in diameter with 30 mm spacing, using a Constant Current High Voltage
Stimulator (Digitimer, Welwyn Garden City, England, model DS7AH). In the present study a
painful electrocutaneous stimulus was used as an unconditioned stimulus (US). The intensity
of painful stimuli were individually set for each of the participants (see 2.3.1 below). In total 96
painful stimuli were delivered during 4 blocks of the experiment (24 stimuli in each block).
Successive painful stimuli were separated by approximately 16 s in the PC and the UC. The
time between successive painful stimuli varied due to the differences in participants’ reaction
times (joystick movements).The participants were not aware that the same intensity stimuli
were delivered to their right hand during the whole experiment (except during the calibration
phase). The mean intensity of the stimuli calculated for individual intensities for all partici-
pants was 17.05 mA, SD = .52 and ranged between 7.5–24 mA.
2.2.2. Colour stimuli and visual stimuli. The colour stimuli were full-screen colour slides
(red and green) displayed on a computer screen (60 Hz refresh rate) facing the participant at a
distance of approximately 50 cm. The red/green colour stimulus was presented for around 6.5
s at the beginning of each trial of the experiment (see Fig 1).
Either the green or red colour acted as a placebo or a control stimulus. The colour stimuli
were counterbalanced and the order of their presentation was pseudorandom (no more than 3
consecutive trials containing the same colour stimulus and CS movements). For half of the
participants from the experimental groups (Group 1 and 3), the green colour was associated
with a placebo-suggestion (information that electrical stimuli following green colour will be
less painful) and the red colour was a control stimulus (non-placebo). For the remaining half
of the participants in the experimental groups, the meaning of colour stimuli was reversed:
green was the control stimulus and red was the placebo stimulus. A total of 192 colour stimuli
were presented: 24 red and 24 green in each block of the experiment.
During the experiment two types of visual stimuli were used: two arrows or a single arrow,
presented during the colour stimulus presentation (see Fig 1). At the beginning, two arrows
(both pointing in the same direction) were presented for 3.5 s and represented a preparation
signal anticipating the direction of the movement to be performed. Participants were asked
Table 1. Characteristics of the subjects in each experimental group: Means (and standard deviations).
Groups N Sex Age
Predictable experimental—Group 1 14 F 24.21(2.46)
Predictable control—Group 2 14 F 24.14(4.66)
Unpredictable experimental—Group 3 14 F 23.50(3.03)
Unpredictable control—Group 4 14 F 22.79(2.61)
N, number of subjects in each experimental group; F, Female
https://doi.org/10.1371/journal.pone.0222805.t001
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not to move the joystick during this visual stimulus presentation. Afterwards, a single arrow
was presented for 1.5 s that always pointed in the same direction as the two arrows. It repre-
sented a starting signal for the joystick movement (leftward arrow–left movement; rightward
arrow–right movement; 32x32 pixels).
2.2.3. Joystick movements. During the testing phase of the experiment (see 2.3.4 below)
the participants were asked to move a Logitech Attack 3 joystick to the left and to the right and
these movements served as conditioned stimuli (CSs). The preparation signal (two arrows)
announced the direction of the movements at the beginning of each trial. The participants
were asked to perform the movement as soon as the starting signal (a single arrow) disap-
peared from the centre of the black background screen. The proper joystick movement was
precisely specified and the participants learned how to move it in the practice phase of the
experiment (see 2.3.3 below).
2.2.4. Startle probe. The startle probe was a burst of white noise with instantaneous rise
time (100dBA, 50 ms) presented binaurally by SONY stereo headphones. Startle probes are
ideal for collecting a startle blink reflex (startle eyeblink reflex—SBR) [33]. The loudness of the
startle probe was measured set using a Sound Pressuremeter Brüel & Kjær (Amplifier Type
2610, microphone 4192, Artificial Ear Type 4153; Denmark). Startle probes were delivered
during the startle habituation phase and testing phase of the experiment (see 2.3.2 and 2.3.4
below).
Fig 1. Design of the testing phase in PC (A) and UC (B). The timing of the trials differs slightly in accordance to the
individual reaction time (movement time). Note: ‘+’ represents fixation cross (FC) when the participants were asked to
focus on the FC; ‘NRS’ represents Numerical Rating Scale used to score pain sensations; red and green triangles
represent counterbalanced colour stimuli used as placebos;➔➔ represents the preparation signal anticipating the
direction of the movement to be performed (right movement in this case);➔ represents the starting signal of the
movement (right movement in this case); CS+ represents a joystick movement always followed by painful stimuli; CS-
represents a joystick movement never followed by painful stimuli in the PC; CSc represents a joystick movement in the
UC; speaker represents the startle probe presentation; lightning represents the painful stimuli application. In the PC
and UC startle probes were delivered during movements (6 with CS+/CSright and 6 with CS-/CSleft in each block of the
experiment), in FC presentation (in 2 trials at 2 s; in 2 trials at 2.5 s; in 2 trials at 3 s, in each block) and at the end of the
trial (in 2 trials at 2 s after the movement; in 2 trials at 2.5 s after the movement; in 2 trials at 3 s after the movement).
https://doi.org/10.1371/journal.pone.0222805.g001
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2.3. Procedure
The present study, analogous to Meulders et al. [11,12,34], consisted of 4 phases: a calibration
phase, a startle habituation phase, a practice phase and a testing phase lasting around 6, 5, 5
and 50 minutes, respectively. The time of testing phase of the experiment vary due to the dif-
ferent reaction times (joystick movements) and did not include between blocks brakes. The
experiment was performed in a sound-attenuated laboratory room. The participants were
seated in a comfortable armchair in front of a computer screen at a distance of roughly 50 cm
with both of their hands resting on the desk or with their right hand holding the joystick and
their left hand placed near the keyboard to be able to use its buttons when it was necessary to
score their pain experience.
An adapted version of the VJMP [11,12,34] was used in order to investigate the placebo
effect. As was the case in the studies of Meulders et al. [11,12,34], two conditions of the experi-
ment were incorporated, namely predictable pain (PC; Group 1 and 2) and unpredictable pain
(UC; Group 3 and 4) in order to elicit fear of movement-related pain and pain-related anxiety,
respectively [11,12,34]. In the PC (in both experimental and control group), one of two possi-
ble joystick movements was always followed by a painful stimulus (the direction of this CS
+ movement was counterbalanced across the participants). In the UC (in both experimental
and control group) pain stimuli were never associated with the joystick movement but were
delivered after a specific inter trial interval (ITI) at the beginning or at the end of the trial (see
Fig 1B).
The adjustment of the VJMP allowed a placebo manipulation to be implemented. Firstly,
the verbal suggestion procedure was introduced to elicit placebo analgesia where colour sti-
muli served as placebos. Secondly, a control condition was incorporated where no suggestion
about the meaning of the colours was provided (control groups). Participants from the experi-
mental groups (Group 1 and 3) were verbally informed about the association between placebo
stimuli and less painful stimuli applications. Such information was also provided during the
experimental procedure in the form of a description presented on the computer screen. In the
control groups no information about the association of placebo stimuli and stimulus intensity
was provided (Group 2 and 4). Crucially, the participants were not aware that they received
the same intensity of stimuli throughout the experiment. Moreover, in the present study par-
ticipants underwent only one experimental condition (PC or UC). Due to this fact the proce-
dure did not include two long-lasting, background sounds that were associated with the PC
and the UC, as was done in the studies of Meulders et al. [11,12,34].
The four phases of the experiment were slightly different in the PC and the UC (see below).
Trial timing was not equal, (some participants took more time to move the joystick).
2.3.1. Calibration phase. The calibration was conducted to select the individual painful
stimuli for each participant. During this phase the participants were asked to rate the intensity
of each stimulus delivered to their forehand on an 11-point numeric rating scale (NRS) rang-
ing from 0 –“no pain”, to 10 –“the strongest pain ever”. Participants were informed that the
experiment was targeting a score of 7 (‘moderate pain’) on the NRS and that 10 on the scale
indicated the intensity that they did not want to receive anymore. To set these individualized
painful stimulus, the participants received one series of electrical stimuli of increasing intensity
(1 mA per step, starting from 0) to the value at which an NRS score of 7 was obtained. Next,
the intensity of electrical stimuli was decreased (0.5 per step) to an NRS score of 6 and next
increased until again a value of 7 on the NRS was obtained. The average of the three values of
the individually scored stimulus intensity that was rated as a 7 on the NRS was used as painful
stimulus during the experiment. The inter-trial interval (ITI) between each of the electrical
stimulus applications was 10 s. During the calibration phase, participants were instructed to
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notify the experimenter when they did not want to proceed to receiving stimulations of higher
intensity.
2.3.2. Startle habituation phase. A startle habituation phase was performed to prevent
potential confounds in the data that could be caused by an increased reaction to first startle
probes. We presented 1 startle probe during 12 consecutive trials. Each trial lasted for 24 s.
The timing of the startle probe presentation was different in each trial (5, 10, 15 and 20 s) and
was randomized over trials for each participant (see [11]). During the startle habituation phase
no painful stimuli were delivered and participants did not perform joystick movements.
2.3.3. Practice phase. In this phase participants had to perform 14 correct joystick move-
ments. The main task was to move the joystick (7 rightward and 7 leftward movements per-
formed in a pseudorandom order) as quickly as possible when a starting signal (left or
rightward arrow) disappeared from the computer screen. Moreover, during this phase, the
participants received detailed feedback to learn how to operate the joystick accurately. They
monitored the joystick movement via a cursor displayed on the computer screen with the tar-
get regions visible. The target region was a big white square presented on the computer screen.
The participants were informed if their movement was performed correctly (text information:
“Good” appeared at the computer screen). Additional error information was provided in the
case of: wrong movement direction (text information: “Wrong direction” if the movement was
performed in the opposite direction to which the single arrow was pointing); incomplete
movement (text information: “Wrong movement” if the cursor did not reach the target
region); slow movement (text information “Too slow”) if the movement lasted more than 3s.
Trials with an incorrect movement were repeated until a correct movement was performed.
Additionally, in the PC (Group 1 and 2) in 7 of 14 trials pain stimuli were delivered after one
of the movements (right or left, counterbalanced across participants). Due to this, the partici-
pants learned the association between a specific movement and pain stimulus application. In
the UC (Group 3 and 4) no pain stimuli were delivered during this phase.
2.3.4. Testing phase. During this phase in both the PC (Group 1 and 2) and the UC
(Group 3 and 4), the colour stimuli, electric shocks and startle probes were presented. The tar-
get region, cursor and error messages were not displayed anymore. Before the testing phase,
the position of the electrode was changed to prevent stimulation of the same skin area–the
electrode was moved slightly away from the palm towards the elbow by approximately 2 cm.
In both conditions of the experiment the participants’ task was to move the joystick as fast and
as accurately as possible after the presentation of the starting signal (single arrow) and score
their pain sensation when the NRS scale appeared on the computer screen.
The experimental phase consisted of 4 blocks of 48 trials each (24 rightward and 24 leftward
movements each). Trial timing and trial types of the PC and UC are presented in Fig 1. Each
trial started with the colour stimulus presentation. In each block there were 24 trials in which
the colour green and 24 trials in which the colour red was presented. The trial order was pseu-
dorandomized. There were no more than 3 consecutive trials of the same joystick movement,
no more than 3 consecutive trials using the same colour stimulus and no more than 2 consecu-
tive trials with the startle probe presentation. During the colour stimulus presentation, the
white fixation cross (FC) and preparation signal (two arrows) were also presented (see Fig 1).
The experimental phase differed slightly between the PC and UC (see Fig 1). In the PC, one
type of movement was always followed by a painful stimulus (CS+ movement). The movement
site associated with pain stimuli was counterbalanced across the participants. One half of par-
ticipants received painful stimuli after the rightward and the other half after the leftward move-
ment. In the UC, pain stimuli were never delivered after joystick movement but were delivered
at the beginning of the trial (during FC) or at the end of the trial, 3–5 s after the movement
Placebo analgesia induced by verbal suggestion in the context of experimentally induced fear and anxiety
PLOS ONE | https://doi.org/10.1371/journal.pone.0222805 September 24, 2019 6 / 19
(see Fig 1). In the PC, in contrast to the UC, the participants were asked to rate their expec-
tances about the intensity of the stimulus they were about to receive (see 2.4.2. for details).
In the PC, the startle probe was presented at one of the following moments during the trial:
during the fixation cross and colour stimulus presentation (6 trials in one block); during the
movement followed by the pain application (CS+; 6 trials in one block); during the movement
not followed by the pain application (CS-; 6 trials in one block); or during the break in between
trials (6 trials in one block) (see Fig 1). In the UC, the startle probe was presented during the
fixation cross and colour stimuli presentation (6 trials in one block) when the pain stimuli was
delivered at the end of the trial; during the right (CSright) and the left movements (CSleft) (6 tri-
als in one block for one movement type); or during the break in between trials (6 trials in one
block) when the pain stimuli were delivered with the FC (see Fig 1).
2.4. Measurements
2.4.1. Pain intensity. In the PC and in the UC of the experiment, the participants rated
their pain sensation after each electric stimulus application on an 11-point Likert scale ranging
from 0 –“no pain” to 10 –“the strongest pain ever” (the intensity that they don’t want to receive
anymore). The scale was presented for 2.5 sec after the pain stimulus application (see Fig 1).
2.4.2. Expectancy of the pain stimuli intensity. In all trials of the PC participants
answered the question “How painful do you expect the stimulus will be after performing the
left/right movement” and scored their sensation on a 11-point Likert scale with ranging from 0
–“no pain” to 10 –“the strongest pain ever”. The scale was presented for 2.5 s, during the colour
stimuli and the preparation signal (two arrows) presentation (see Fig 1). It should be men-
tioned that in the UC expectancy ratings were not collected due to the characteristics of the
procedure–unpredictability of the stimulus application.
2.4.3. Defensive conditioning responses. Regarding retrospective fear of movement-
related pain during the CSs, for both conditions of the experiment, after each block the partici-
pants answered the question “How fearful were you to perform the right/left movement”. The
answer was scored on an 11-point Likert scale ranging from 0 –“not fearful at all” to 10 –“the
worst fear I can imagine”. They were asked about fear of performing the CS+ movement and
also the CS- movement in the PC and about fear of performing the CS to right (CSright) and
left (CSleft) side in the UC.
Regarding response latency and duration, the start region and target region of the joystick
movement were identified by a small and a large circle presented on the computer screen,
respectively. These circles were visible only during the practice phase. Response latency (move-
ment initiation latency time) was defined as the time to start the joystick movement in accor-
dance to the direction pointed by the arrow stimulus. Response latency (T1) was technically
defined as the time from the moment of disappearance of the arrow until participants left the
start region (small circle). The small circle was placed in the middle of the screen (17” size and
resolution 1920:1080). The radius of the small circle was r = 52 pixels. Response duration (T2)
was defined as the time from leaving the small circle (start region) until leaving the large circle
(target region), which indicated that participants had successfully completed a movement. The
radius of the large circle was r = 370 pixels. A correct movement was defined as reaching the
left/right hemisphere of the large circle.
For both T1 and T2 reaction times under 0.2 s, above 3 s and larger than 2.5 SD from the
truncated mean of its corresponding cell in the experimental design (the mean for all trials of
the participants in the given experimental group) were discarded from the analysis in accor-
dance with Lachaud et al. [35]. The removed data are: (1) Group 1: 9.7% of trials of T1 and
6.69% of trial of T2; (2) Group 2: 20.31% of trials of T1 and 13,54% of trial of T2; (3) Group 3:
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13.16% of trials of T1 and 6.84% of trial of T2; (4) Group 4: 11,94% of trials of T1 and 7.44% of
trial of T2. From the remaining data, the mean reaction time for each participant was calcu-
lated for each CS movement in each experimental group (CS+, CS-, CSright and CSleft).
2.4.4. Eye blink startle modulation. The eye blink startle responses collected during the
CS movements were used as psychophysiological correlates of FMRP and CRPA, indexed by
ITI startle responses. The orbicularis oculi electromyography activity (EMG) was recorded
with four electrodes: two attached to the external canthi of both eyes (monitoring horizontal
eye movement) and one above and one below the left eye (monitoring vertical movement, i.e.
blinks). The EMG ground electrode was placed on the nose. Signals were recorded with a
Brain Vision Recorder (Brain Products, Munich, Germany) using a 150 Hz low-pass filter,
with a time constant of 10 s (0,016 Hz) and a 500 Hz sampling frequency. The signal from the
complete experiment was digitized at 1000 Hz and MatLab R2013a software (student edition)
was used to perform postprocessing. First, EEG data were loaded using EEGLAB
Toolbox (Version 14.0.0). Secondly, data were manipulated according to [33] by performing
rectification, variable-weight FIR filtering (101 coefficients, low-pass cut-off frequency 40Hz),
and vertical movement electrodes signal summation. The summed signal was then epoched
about the startle probe marker (marking the 0 ms origin) in the range -200 ms to 1000 ms.
Analogously to Meulders et al. [11,12], the summed signal was baselined by averaging the sig-
nal in the range -20 ms to 0 ms. The peak amplitudes were defined as the maximum of the
response curve within 21–175 ms after the startle probe onset. Startle waveforms (raw signal
for all four electrodes) were visually inspected off-line in order to exclude technical abnormali-
ties and artefacts. Participants with no observed blink responses in either CS or ITI were
excluded from the data set. Averages were calculated for responding during CS movements
(CS+, CS-, CSright and CSleft) and ITI (mean startle amplitude collected during FC and during
the break in between trials) separately for both the PC and the UC. Data collected from 20 par-
ticipants from the PC and 20 participants from the UC were used in further statistical analysis.
3. Statistical analysis
In order to test our hypotheses, data from the testing phase of the study were analysed. The
NRS pain intensity ratings were averaged from blocks 1 to 4 in the PC and the UC. Two depen-
dent variables were analysed: (1) the mean pain intensity of placebo- and non-placebo-associ-
ated pain ratings and (2) the mean difference between placebo- and non-placebo-associated
pain ratings in experimental groups; and the mean difference between red- and green-associ-
ated pain ratings in control groups. Note that in control conditions placebo and non-placebo
stimuli refer to mean ratings of green- and red- associated stimuli, respectively. Similarly, the
NRS expectancy of the pain intensity ratings, from blocks 1 to 4 in the PC, were averaged, and
dependent variables were analysed: (1) the mean placebo- and non-placebo-associated expec-
tancy of pain intensity ratings3 and (2) the mean difference between placebo- and non-pla-
cebo-associated expectancy of pain intensity ratings in the experimental group; and the mean
difference between red- and green-associated expectancy of pain intensity ratings in the con-
trol group.
3.1. Analysis of variance
Separate repeated measures ANOVAs were conducted for each dependent variable: NRS pain
intensity ratings and NRS expectancy of pain intensity. A repeated measures ANOVA for NRS
pain intensity ratings, with Condition (predictable and unpredictable) and Group (experimen-
tal and control) as between-subjects factors and Placebo (placebo and non-placebo stimuli) as
a within-subjects factor was performed. For NRS expectancy of pain intensity scores, the
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repeated measures ANOVA with between-subjects factor Group (experimental and control)
and within-subjects factor Placebo (placebo and non-placebo stimuli) was computed.
In order to test whether verbal suggestion was effective, the repeated measures ANOVA
was followed by within-group planned comparison tests: (1) placebo- versus non-placebo-
associated NRS ratings in the experimental group, and (2) red-control versus green-control
NRS ratings in the control group. In the next step of the analyses, in order to investigate
whether placebo analgesia was elicited, between-group planned comparison tests were per-
formed on the difference in pain intensity ratings between non-placebo- and placebo-associ-
ated stimuli from the experimental groups compared with the difference in pain intensity
ratings between red-control and green-control stimuli from the control groups.
In order to test whether verbal suggestion elicited differences in participants’ expectancy
(only PC), within-group planned comparison tests were performed for the expected pain
intensity scores: (1) placebo- versus non-placebo-associated expectancy of pain intensity scores
in the experimental group, and (2) red-control versus green-control expectancy of pain inten-
sity scores in the control group.
3.2. Regression analysis
Linear regression analysis was performed for the PC to determine the degree to which the pla-
cebo analgesia was predicted by the expected pain intensity. To do this, the mean difference in
pain intensity ratings between placebo- and non-placebo-associated stimuli was set as the
dependent variable, while the mean differences in the expected pain intensity scores between
placebo- and non-placebo-associated stimuli served as an independent variable.
3.3. Defensive conditioning responses–manipulation check
In order to investigate if CS+ movements in the PC elicit elevated defensive conditioning
responses, for (1) self-reported fear, (2) response latencies (T1), and (3) response duration
(T2), repeated measure ANOVAs with Condition (predictable and unpredictable) as a
between-subjects factor and Movement Type (CS+/right, CS-/left) as a within-subjects factor
were performed. CS+ and CS- refer to predictable condition and CSright and CSleft refer to the
unpredictable condition. The F-tests were followed by planned comparisons in order to com-
pare the magnitudes of self-reported fear between each movement type (CS+/right, CS-/left)
for both experimental conditions (PC and UC).
Additionally, the startle modulation data (eye blink amplitudes) were analysed with a
repeated measure ANOVA with Condition (predictable and unpredictable) as a between-sub-
jects factor and Startle Type (CS+/right, CS-/left and ITI)4 as a within-subjects factor. Next, F-
tests were followed by the post-hoc pairwise comparison with Bonferroni correction in order
to compare the magnitude of the three types of startle amplitudes.
4. Results
The descriptive statistics for pain intensity ratings and expectancy of the pain intensity are pre-
sented in Table 2.
All results of the repeated measures ANOVA on the NRS ratings are presented in Table 3.
The repeated measures ANOVA of the NRS ratings revealed a statistically significant main
effect of Placebo (F(1,52) = 11.62, p< .001, η2 = .03) and a statistically significant interaction of
Placebo × Group (F(1,52) = 9.85, p = .003, η2 = .03).
Within-group planned comparison tests on the NRS ratings (see Table 3) revealed a statisti-
cally significant difference in the experimental groups (Group 1 and Group 3, mean difference
.34 ± .07), indicating that pain stimuli associated with the placebo suggestions were rated as
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less painful than the non-placebo ones. No such effect was observed in the control groups
(Group 2 and 4, mean difference .01 ± .07).
Between-group planned comparison tests on the difference in pain intensity ratings
between non-placebo- and placebo-associated stimuli from the experimental groups (mean .34
± .54) compared with the difference in pain intensity ratings between red-control and green-
control stimuli from the control groups (mean .01 ± .13) was performed. It revealed a statisti-
cally significant effect (see Table 3 and Fig 2), indicating that placebo analgesia was induced by
verbal suggestion in the experimental groups.
All results of the repeated measures ANOVA on the expectancy of pain intensity scores are
presented in Table 4, showing a statistically significant main effect of the Placebo (F(1,26) =
15.46, p< .001, η2 = .30) and a significant interaction effect of Placebo × Group (F(1,26) =
10.653, p = .003, η2 = .20). Within-group planned comparison (see Table 4 and Fig 3) on non-
placebo- versus placebo-associated expectancy of pain intensity scores revealed a statistically
significant difference for the experimental group (Group 1, mean difference 1.34 ± .26), indi-
cating that verbal suggestion had an effect on expectancy of pain intensity. By contrast, no sta-
tistically significant difference was found between two control stimuli (red and green) in the
control group (Group 2, mean difference .13 ± .26).
A simple linear regression was performed to predict the magnitude of the placebo effect
based on expectancy of pain intensity scores. It revealed a significant regression equation
Table 2. Descriptive statistics for pain intensity ratings, expectancy of pain intensity score.
Variables Stimulus Group 1 Predictable
experimental
Group 2 b Predictable
control
Group 3 Unpredictable
experimental
Group 4b Unpredictable
control
Pain
intensity
Placebo 4.48±1.93 3.65±1.44 3.87±1.26 3.85±.79
Non-placebo 4.95±1.91 3.69±1.42 4.10±1.16 3.84±.74
Differencea .46± .64 .04±.12 .22±.41 -.01±.14
Expectancy Placebo 3.61± 1.85 3.26±1.54
Non-placebo 4.96±1.49 3.38±1.61
Differencea 1.35±1.35 .13±.25
aDifference between NRS ratings of non-placebo- or placebo-associated stimuli;
bIn the control group both stimuli were set up at the same level of intensity, therefore the difference presented here can be considered as a difference between red- and
green-associated NRS ratings.
https://doi.org/10.1371/journal.pone.0222805.t002
Table 3. The results of repeated measures ANOVA on the pain intensity ratings.
Main effects and interactions F df P η2
Placebo 11.62 1,52 < .001 .03
Group 2.58 1,52 .12 .37
Condition .56 1,52 .45 .00
Placebo × Condition 1.90 1,52 .174 .01
Placebo × Group 9.85 1,52 .003 .03
Placebo × Group × Condition .881 1,52 .352 .00
Within-group planned comparisons F df P η2p
Experimental groups (placebo-associated stimuli vs non-placebo-associated stimuli) 21.44 1,52 < .001 .29
Control groups (green-control stimuli vs red-control stimuli) .04 1,52 .85 .00
Between-group planned comparisons F df P η2
The mean difference in NRS pain scores between placebo- and non-placebo stimuli from the experimental groups
vs the mean difference between two control (red and green) stimuli from the control groups.
9.71 1.54 .003 .15
https://doi.org/10.1371/journal.pone.0222805.t003
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(F(1,26) = 8.85, p = .006) with R2 of .254. A positive correlation was found between the placebo
effect and the expectancy of pain intensity scores (r = .504, p = .003), and the regression model
predicted 25.4% of the variance.
Results of the repeated measures ANOVA performed on self-reported fear ratings revealed
statistically significant main effects of Condition (F(1,54) = 50.51, p< .0001, η2 = .38) and Move-
ment Type (F(1,54) = 28.36, p< .001, η2 = .21). Moreover, a statistically significant interaction of
Condition × Movement Type (F(1,54) = 9.85, p = .003, ηp2 = .03) was also observed. Planned
comparison tests revealed that in the PC, participants were more afraid of CS+ movement than
CS- movements (F(1,54) = 77.29, p< .001, ηp2 = .09). No difference between self-reported fear of
CSright and CSleft in the UC was found (F(1,54) = 1.58, p> .05, ηp2 = .03) (see Fig 4).
The repeated measures ANOVA performed on response latencies (T1) revealed a statisti-
cally significant main effect of Condition (F(1,54) = 4.77, p = .03, η2 = .08) indicating that partic-
ipants were slower in initiating a movement in the PC compared to the UC (mean .47 ± .09
and .43 ± .07, respectively). No statistically significant main effect of Movement Type (F(1,54) =
2.59, p> .05, η2 = .05) nor an interaction of Condition × Movement Type (F(1,54) = .19, p>
.05, η2 = .003) was found.
Results of the repeated measures ANOVA performed on response duration (T2) revealed a
statistically significant main effect of Condition (F(1,54) = 4.43, p = .04, η2 = .08), indicating
slower joystick movements in the PC compared to the UC (mean .54 ± .10 and .49 ± .08,
Fig 2. Placebo effect. The difference in pain intensity ratings between non-placebo and placebo-associated stimuli
from the experimental groups and the difference in pain intensity ratings between red-control and green-control
stimuli from the control groups.
https://doi.org/10.1371/journal.pone.0222805.g002
Table 4. The results of repeated measures ANOVA on the expectancy of pain intensity.
Main effects and interactions F df P η2
Placebo 15.46 1,26 < .001 .30
Group 2.69 1,26 .113 09
Placebo × Group 10.65 1,26 .003 .20
Within group planned comparisons F df P η2p
Experimental groups (placebo-associated stimuli vs non-placebo-associated stimuli) 25.88 1,26 < .001 .49
Control groups (green-control stimuli vs red-control stimuli) .64 1,26 .22 .01
https://doi.org/10.1371/journal.pone.0222805.t004
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respectively). No statistically significant main effect of Movement Type (F(1,54) = .05, p> .05,
η2 = .001) nor an interaction effect of Condition × Movement Type (F(1,54) = 1.67, p> .05, η2
= .03) was found. The obtained results for T1 and T2 suggest no differences between move-
ment types.
Fig 3. Expectancy of pain intensity scores in the predictable condition. In experimental group (only PC), verbal
suggestion about the analgesia had an effect on expectancy of pain intensity.
https://doi.org/10.1371/journal.pone.0222805.g003
Fig 4. Fear ratings associated with the type of movement. In the PC, the level of fear was the highest for the
movement associated with pain application (CS+) compared to the movement never associated with pain application
(CS-). In the UC, no difference was found for fear level associated with the CSright and CSleft movements.
https://doi.org/10.1371/journal.pone.0222805.g004
Placebo analgesia induced by verbal suggestion in the context of experimentally induced fear and anxiety
PLOS ONE | https://doi.org/10.1371/journal.pone.0222805 September 24, 2019 12 / 19
An additional repeated measures ANOVA performed on the startle response amplitude
revealed significant main effects of Condition (F(2,76) = 4.92, p = .03, η2 = .12) and Startle Type
(F(2,76) = 4.83, p = .01, η2 = .11). However, no significant Startle Type × Condition interaction
was found, indicating that the startle amplitude in response to the ITI and the different CSs
movements did not differ significantly for both experimental conditions (F(2,76) = 1.32, p = .27,
η2 = .03). Startle reflexes in the PC were higher than in the UC (360.71 ± 162.06 and
282.69 ± 124.09, respectively). Pairwise comparisons with Bonferroni correction performed
for the three types of startle response revealed that CS+ and CS- startle response do not differ
(p>. 05); however, both have higher amplitudes compared to the ITI startle amplitude (p<
.05 for comparison of both CS+ and CS- with the ITI startle responses).
5. Discussion
In the present study, we examined using VJMP [12] if FMRP and CPRA have different effects
on the magnitude of placebo analgesia induced by verbal suggestion. Moreover, an attempt
was made to investigate if induced placebo analgesia can be predicted by expectancy of pain
intensity (only PC). The results were largely in line with the predictions.
5.1. Placebo effect and negative emotional states
Placebo analgesia was induced in both experimental conditions. This result is coherent with pre-
vious findings showing that verbal suggestion is sufficient to induce the placebo effect [16–20].
Aside from the studies of Meulders et al. [11,12,34], only a few studies focused on the diver-
gent effects of fear/anxiety on pain sensitivity [10,36]. To our knowledge no such attempt was
made in the context of placebo effects. In contrast to our expectations, we did not observe any
divergent effects of FMRP and CPRA on the magnitude of the placebo effect. This result con-
tradicts our hypothesis that a weaker placebo effect would be elicited in the UC. Our results
suggest that state fear and state anxiety influence the placebo effect in the same manner. How-
ever, this conclusion needs further investigation where control group with neither fear nor
anxiety elicitation is included in the study design. Such control group is difficult to create in
the modified joystick paradigm. Therefore, this issue should be resolved using a distinct
paradigm.
However, we cannot exclude that differences in the magnitude of the placebo effect induced
in the context of state fear and anxiety exist. Such differences may be visible with different
intensities of particular emotional states. The emotions level can be manipulated by changing
the duration, intensity or the location of pain stimuli [37]. However, in the present study nei-
ther fear nor anxiety levels were manipulated. Therefore, future investigation is needed.
Moreover, the measurement of the placebo effect (via verbal ratings) might not be suffi-
ciently precise and sensitive to capture the influence of FMRP and CPRA. Behavioural mea-
surements of pain have been shown to be less sensitive because they are the end product of all
preceding cumulative cognitive operations and are more vulnerable to noise and variability.
EEG studies could be more effective in capturing the differences in the magnitude of the pla-
cebo effect in both PC and UC, as previous studies showed that placebo suggestions decreased
brain activity in the regions related to anxiety processing [38,39].
5.2. Placebo effect and expectancy
The effects of verbal suggestion are considered to be mediated by expectancies [20,23–26]. To
our knowledge there is only one study in which expectations were found to influence the
nocebo effect induced by verbal suggestion [40]. In the present study, the participants expected
less pain in relation to placebo stimuli than non-placebo stimuli. Moreover, it was
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demonstrated that the placebo effect was predicted by expectancy which is in line with the
expectancy theory [24,41] and Colloca and Miller’s [23,42] learning model. Specifically, verbal
information about pain decrease elicits expectations and modulates pain perception. To the
best of our knowledge, this is the first study in which the placebo effect induced by verbal sug-
gestion only (without conditioning nor other interventions) was found to be predicted by
expectations. Bu¨chel et al. [43] proposed a theory linking expectancy and the placebo effect.
They suggested that “combining top-down prior expectations or predictions of pain (relief)
with bottom-up sensory signals at multiple levels of the neural hierarchy” induces placebo
analgesia. Moreover, they stressed the role of precision and certainty of the expectancy in elic-
iting the placebo effect. Based on their work and studies on neurobiological mechanisms of the
placebo effect [44,45], it is speculated that modulatory neurotransmitters, such as opioids [46]
or dopamine [47,48], might be related to the characterization of expectations induced by ver-
bal suggestions. It is suggested to investigate in the future the EEG correlates of expectations
such as contingent negative variation (CSV) that is elicited before an incoming painful stimu-
lation. This central EEG measures were used in the study of Piedimonte et al. [49] where
authors used an expectation paradigm with and without conditioning procedure and focused
on the expectation in placebo and nocebo effect.
5.3. Manipulation check
Results obtained for self-reported fear revealed that the manipulation performed in PC suc-
ceeded in eliciting FMRP. Specifically, as we predicted, elevated fear ratings were observed for
CS+ movements compared to CS- movements, suggesting that our fear conditioning proce-
dure was effective. This result is in line with the results obtained in other studies where VJMP
was used [11,12] and indicates that FMRP can be elicited not only by social learning [50,51]
but also by experience.
Analysis performed for the T1 and T2 partially indicates that FMRP and its accompanying
avoidance behaviour were induced. In comparison to UC, in PC the participants were more
reluctant to initiate movements (T1) and they needed more time to perform the movements
(T2). However, in contrary to previous findings of Meulders et al. [11,12], the participants in
PC did not show a tendency to avoid CS+ movements more than CS- movements.
As in the present study, Meulders et al. [12] could not provide a conclusive explanation for
their findings that T2 for CS+ and CS- movements did not differ. Results obtained for both T1
and T2 might be associated with strict preprocessing of raw data—we discarded high percent-
ages of trials from the analysis (see 2.4.3). The filtering of reaction time data may introduce a
bias [35]. Another explanation, which is supported by the amount of discarded data, is that
there may have been some procedure apparatus problems. It is highly probable that the joy-
stick movement sensitivity could have been too high (e.g. the radius of the small circle was too
small) resulting in a high number of trials below 0.2 s).
The startle response amplitude was shown to be higher in the PC compared to the UC
regardless of the type of startle, which suggests the presence of elevated conditioned defensive
response in the PC. Moreover, regardless of the experimental condition, CS+/CSright and CS-/
CSleft startle responses had higher amplitudes than those associated with ITI startle. Startle
measures were not elevated more in response to the CS+ than to the CS-, which contradicts
previous findings [11,12] and which may possibly be related to the small number of trials col-
lected for each startle.
It is suggested that results obtained for self-reported fear, T1, T2 and startle responses may
indicate that in both experimental conditions differences in emotional arousal were present
and that FMRP and CFRA were successfully elicited. In accordance with Davis et al. (for
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review see [52]), the sustained response to temporally uncertain danger is associated with the
elicitation of anxiety, one of two primary defensive behavioural states. The second defensive
behavioural state is fear, which is defined as a phasic response to imminent threat. Crucially,
both responses are shown to be subserved by distinct neural substrates [53]. Another argument
supporting this assumption arises from a study in which unpredictability of pain application
was shown to elicit CPRA [11–13]. In those studies CPRA was indexed by elevated ITI startle
responses in the UC compared to the PC. Therefore, it can be assumed that our procedure
used to elicit FMRP and CRPA was effective, even though there was no difference between the
CS+ and CS- startle response nor between the UC and PC ITI startle responses.
5.4. Limitations
Some limitations of the present study should be acknowledged. First, only healthy female par-
ticipants were tested. Therefore, the conclusions of this research are applicable to the healthy
female population only. Second, as explained before, our joystick settings might have been too
sensitive. It is also probable that no differences in the magnitude of the placebo effect between
the PC and the UC could be associated with insufficient unpredictability of pain stimuli in the
latter. Pain stimuli in the UC could have been associated with ITI startle probe presentation
what would have made this condition less unpredictable. It is suggested to use STAI question-
naire at the beginning of the experiment to be able to check if the anxiety level for both groups
is the same.
5.5. Conclusions
Placebo analgesia was observed in both the PC and the UC; however, no differences were
found in the magnitude of the effect between both experimental conditions. For the first time
expectancy was shown to predict the placebo effect induced via verbal suggestion in a context
of experimentally induced state fear. Finally, some of our manipulation checks (eyeblink startle
and self-reported fear) indicate that FMRP and CPRA were successfully elicited in the PC and
the UC, respectively. Further research using objective measures, such as EEG, is required to
investigate the differential role of fear, anxiety and expectation in the placebo effect induction.
Next, it is recommended to collect trial-by-trial fear ratings and investigate if the level of
FMRP, as in the case of physical performance and self-reported disability [54–56], may predict
the placebo effect. Finally, it is suggested to implement a modification in the experimental
design in which different predictability dimensions are used.
5.6. Implications
The adjusted VJMP is a promising research tool that opens a new field of research on the pla-
cebo effect in the experimental context of maintenance of chronic musculoskeletal pain. More-
over, in the future, the adjusted VJMP will allow to investigate how the reduction of FMRP
and CPRA influences the magnitude of the placebo effect (the method of reducing both emo-
tional states can be found in Meulders et al. [13]). Moreover, VJMP may be implemented to
test chronic pain patients and compare them with other clinical populations or healthy partici-
pants; however, taking into account the preliminary character of the present study, further
investigation is needed before the investigation reaches clinical conditions.
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